glp 1 agonist alcohol GLP-1 Anti-Obesity Rx and and Substance Use Disorders GLP-1 Agonists for Alcohol Use

Bedside ultrasound assessment of gastric content: an observational study

[DOI] [PubMed] [Google Scholar] 4.Batta A, Hatwal J

This rigorous evaluation has led to the accelerated recognition of the cardioprotective, renoprotective, and vasoprotective effects of SGLT2i ( Figure 1 )

Some data suggests that higher doses of tirzepatide may be associated with a higher risk of gastrointestinal issues compared to semaglutide

Semaglutide (also injected weekly) was associated with an average weight loss of around 11% after 24 to 68 weeks, with evidence suggesting the effect can persist for up to two years, based on 18 randomized controlled trials (27 949 participants)